In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cascade eyes AcuNetx purchase for optical tech growth

This article was originally published in Clinica

Executive Summary

Imaging firm Cascade Technologies is aiming to boost its product portfolio after signing a letter of intent to purchase AcuNetx. As well as serving the law enforcement, communications and workplace safety industries, AcuNetx manufactures diagnostic, analytical and therapeutic devices that help healthcare providers diagnose and treat balances disorders and bone deficiencies. Cascade (Beverly Hills, California) described these technologies as being complementary to its own range of medical imaging products, which includes noninvasive imaging systems, originally developed for satellite reconnaissance, but now used to diagnose cancer and precancerous conditions. Financial terms within the letter of intent were not disclosed.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts